xarelto 10mg used in the treatment and prevention of blood clots, which may arise due to deep vein thrombosis (DVT), surgery or atrial fibrillation. The active ingredient of the medicine – rivaroxaban – works by inhibiting vital factors in the blood clotting process.
Xarelto is a medicine used in the treatment of deep vein thrombosis (DVT). Untreated DVT can lead to pulmonary embolism, a condition characterised by insufficient blood flow to the lungs. The active ingredient of Xarelto – rivaroxaban – is an oral anticoagulant drug which is well absorbed from the gut.
More specifically, Xarelto is a direct factor Xa inhibitor. Factor Xa is an important element of the clotting process. Rivaroxaban, as a result of inhibiting factor Xa, increases the risk of bleeding, not least because the body finds it challenging to clot wounds including nosebleeds.
Deep Vein Thrombosis – Recurrent Event
xarelto 10 mg composition is used to reduce the risk of recurrent blood clot formation in the blood vessels of the legs and other extremities in patients who are at risk of recurrent deep vein thrombosis following at least 6 months of standard anticoagulant treatment.
Pulmonary Embolism – Recurrent Event
This medicine is used to reduce the risk of recurrent blood clot formation in the blood vessels of the lungs in patients who are at risk of a recurrent pulmonary embolism following at least 6 months of standard anticoagulant treatment.
The missed dose of this medicine should be taken as soon as possible. xarelto 10 mg compensat is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not double the dose to make up for the missed one.
Seek emergency medical treatment or contact the doctor in case of an overdose.
- Back pain
- Dark colored urine
- Bleeding gums
When not to use?
xarelto 10 mg alternative is not recommended for use in patients with a known allergy to rivaroxaban or any other inactive ingredients present along with this medicine.
This medicine is not recommended for use in patients with an active bleeding disorder since it may worsen the patient’s condition.
Breast-feeding – This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.
Use in pediatrics – xarelto 10 mg indication is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.
Surgery or Operations – This medicine should be stopped at least 24 hours prior to undergoing any surgical procedure. It should be restarted as soon as hemodynamic stability is established following the surgical procedure. Replacement with a suitable alternative may be required for some patients both during the procedure and after the procedure based on the clinical condition.